vpa have be associate with neural tube defect in the develop human fetus for this reason and because fec100 use in this trial be also know to be teratogenic woman of child-bearing potential and men must agree to use adequate contraception hormonal or barrier method of birth control abstinence prior to study entry and for the duration of study participation participating men must use condom while on study and for at least 3 month after the trial have end should a woman become pregnant or suspect she be pregnant while participating in this study she should inform her treat physician immediately 